Search research articles
Contact Us
Filters
Showing results (151-160 of 527) with videos related to
Page
of 53
Sort By:
The Kaohsiung Journal of Medical Sciences
|
June 12, 2017
Pegylated interferon plus ribavirin combination therapy in postliver transplant recipients with recurrent hepatitis C virus infection
Ta-Ya Lin, Ming-Lun Yeh, Ching-I Huang, et al.
World Journal of Gastroenterology
|
July 15, 2005
Co-infection of SENV-D among chronic hepatitis C patients treated with combination therapy with high-dose interferon-alfa and ribavirin
Chia-Yen Dai, Wan-Long Chuang, Wen-Yu Chang, et al.
Antiviral Research
|
July 30, 2005
Polymorphisms in the interferon-gamma gene at position +874 in patients with chronic hepatitis C treated with high-dose interferon-alpha and ribavirin
Chia-Yen Dai, Wan-Long Chuang, Wen-Yu Chang, et al.
The Kaohsiung Journal of Medical Sciences
|
June 6, 2025
A Point-of-Care Model for Hepatitis C Elimination in Remote Islands of Taiwan
Tzu-Chun Lin, Pei-Chien Tsai, Chung-Feng Huang, et al.
Journal of Gastroenterology and Hepatology
|
December 12, 2013
Treatment efficacy of pegylated interferon plus ribavirin therapy in chronic hepatitis C patients with mixed genotype 1/2 infection
Ching-I Huang, Chung-Feng Huang, Jee-Fu Huang, et al.
Hepatology International
|
November 15, 2018
Post-treatment fibrotic modifications overwhelm pretreatment liver fibrosis in predicting HCC in CHC patients with curative antivirals
Chung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, et al.
Hepatology International
|
July 24, 2015
Hepatitis C viremia interferes with serum hepatitis B virus surface antigen and DNA levels in hepatitis B uremics
Chung-Feng Huang, Ming-Lun Yeh, Jia-Jung Lee, et al.
The Kaohsiung Journal of Medical Sciences
|
November 17, 2016
Lamivudine switch therapy in chronic hepatitis B patients achieving undetectable hepatitis B virus DNA after 3 years of entecavir therapy: A prospective, open-label, multicenter study
Ming-Lun Yeh, Ching-I Huang, Ming-Yen Hsieh, et al.
International Journal of Medical Sciences
|
April 2, 2014
Discrepancy between serological and virological analysis of viral hepatitis in hemodialysis patients
Jer-Ming Chang, Chung-Feng Huang, Szu-Chia Chen, et al.
BMC Infectious Diseases
|
April 13, 2005
High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study
Ming-Lung Yu, Chia-Yen Dai, Shinn-Cherng Chen, et al.
Page
of 53
Search research articles
Search
Showing results (151-160 of 527) with videos related to
Sort By:
Page
of 53
The Kaohsiung Journal of Medical Sciences
|
June 12, 2017
Pegylated interferon plus ribavirin combination therapy in postliver transplant recipients with recurrent hepatitis C virus infection
Ta-Ya Lin, Ming-Lun Yeh, Ching-I Huang, et al.
World Journal of Gastroenterology
|
July 15, 2005
Co-infection of SENV-D among chronic hepatitis C patients treated with combination therapy with high-dose interferon-alfa and ribavirin
Chia-Yen Dai, Wan-Long Chuang, Wen-Yu Chang, et al.
Antiviral Research
|
July 30, 2005
Polymorphisms in the interferon-gamma gene at position +874 in patients with chronic hepatitis C treated with high-dose interferon-alpha and ribavirin
Chia-Yen Dai, Wan-Long Chuang, Wen-Yu Chang, et al.
The Kaohsiung Journal of Medical Sciences
|
June 6, 2025
A Point-of-Care Model for Hepatitis C Elimination in Remote Islands of Taiwan
Tzu-Chun Lin, Pei-Chien Tsai, Chung-Feng Huang, et al.
Journal of Gastroenterology and Hepatology
|
December 12, 2013
Treatment efficacy of pegylated interferon plus ribavirin therapy in chronic hepatitis C patients with mixed genotype 1/2 infection
Ching-I Huang, Chung-Feng Huang, Jee-Fu Huang, et al.
Hepatology International
|
November 15, 2018
Post-treatment fibrotic modifications overwhelm pretreatment liver fibrosis in predicting HCC in CHC patients with curative antivirals
Chung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, et al.
Hepatology International
|
July 24, 2015
Hepatitis C viremia interferes with serum hepatitis B virus surface antigen and DNA levels in hepatitis B uremics
Chung-Feng Huang, Ming-Lun Yeh, Jia-Jung Lee, et al.
The Kaohsiung Journal of Medical Sciences
|
November 17, 2016
Lamivudine switch therapy in chronic hepatitis B patients achieving undetectable hepatitis B virus DNA after 3 years of entecavir therapy: A prospective, open-label, multicenter study
Ming-Lun Yeh, Ching-I Huang, Ming-Yen Hsieh, et al.
International Journal of Medical Sciences
|
April 2, 2014
Discrepancy between serological and virological analysis of viral hepatitis in hemodialysis patients
Jer-Ming Chang, Chung-Feng Huang, Szu-Chia Chen, et al.
BMC Infectious Diseases
|
April 13, 2005
High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study
Ming-Lung Yu, Chia-Yen Dai, Shinn-Cherng Chen, et al.
Page
of 53